Subject Numbers Regarding Health Provider Authorizations

Authorization No. 123230-5W

January 6, 2017

Pursuant to Workers' Compensation Law Section 13-d(4), the Chair of the New York State Workers' Compensation Board has exercised his authority to temporarily suspend Dr. Sheikh A. Qadeer’s authorization to treat injured workers within the New York State workers’ compensation system effective January 6, 2017. Dr. Qadeer's last known business address is 66 Main Street, Big Flats, New York 14814.

The Chair’s designee’s investigation has revealed that the New York State Department of Health, State Board for Professional Medical Conduct (BPMC) has issued Order #16-417, wherein Dr. Qadeer pled no contest to the Second and Third Specifications, including that he failed to appropriately document a patient’s mental status examination, and drug and alcohol history, and that he failed to document his diagnostic impressions and proposed treatment plan for a patient. This resulted in a limitation precluding Dr. Qadeer from registration or issuance of any further license, and that he shall be precluded from practicing medicine in New York State, from practicing in any setting where his practice is based solely on his New York License, and from any further reliance upon his New York license.

Therefore, the Chair believes that Dr. Qadeer may be guilty of misconduct, and that such misconduct would detrimentally affect the quality of care provided to injured workers.

Dr. Qadeer is prohibited from rendering treatment and care to injured workers while his authorization is temporarily suspended. Reports submitted by Dr. Qadeer for services rendered prior to January 6, 2017, are valid, but are invalid for any services rendered on or after that date. Requests to cross-examine Dr. Qadeer for services rendered prior to January 6, 2017, should not be denied due to the suspension of his authorization.

This suspension remains in effect until further notice. Any questions regarding the authorized lists should be referred to the Medical Director’s Office at 1 (800) 781-2362.